CA SB1500

Exempts clinical trial sites from licensing requirements for storing or preparing human whole blood, whole blood derivatives, and other biologics intended solely for investigational use conducted under federal Food, Drug, and Cosmetic Act requirements.

Exempts clinical trial sites from tissue bank licensing requirements for storing or preparing tissue intended solely for investigational use under specified federal regulatory provisions.

Extends the sunset date from January 1, 2023 to January 1, 2028 for the home medical device retail facility inspection exemption for accredited facilities, which allows complaint-based inspections only instead of annual inspections.

Establishes different inspection requirements effective January 1, 2028: accredited facilities will require annual inspections, replacing the complaint-based inspection model.